Aldeyra Therapeutics, Inc. (ALDX) Social Stream
ALDEYRA THERAPEUTICS INC (ALDX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ALDEYRA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-29 | 5 | $26 | $16 | $22.5 | $3.23 | 596.59% |
| 2022-01-23 | 4 | $21 | $10 | $15.8 | $3.23 | 389.16% |
| 2022-03-18 | 5 | $21 | $10 | $15.8 | $3.23 | 389.16% |
| 2022-05-26 | 5 | $21 | $10 | $15.4 | $3.23 | 376.78% |
| 2022-06-10 | 5 | $26 | $11 | $16.6 | $3.23 | 413.93% |
| 2022-10-13 | 4 | $26 | $13 | $17 | $3.23 | 426.32% |
| 2023-03-10 | 5 | $26 | $13 | $17 | $3.23 | 426.32% |
| 2023-05-11 | 5 | $28 | $13 | $17.4 | $3.23 | 438.7% |
| 2023-06-15 | 5 | $25 | $13 | $16.8 | $3.23 | 420.12% |
| 2023-10-08 | 4 | $25 | $14 | $16.8 | $3.23 | 420.12% |
| 2023-10-17 | 4 | $15 | $8 | $12.25 | $3.23 | 279.26% |
| 2023-11-01 | 4 | $15 | $7 | $10.25 | $3.23 | 217.34% |
| 2023-11-28 | 4 | $15 | $7 | $10 | $3.23 | 209.6% |
The Trend in the Analyst Price Target
Over the past 32 months, ALDX's average price target has gone down $16.67.
Over the past 44 weeks, ALDX's average upside potential has been 170.28%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 5 | 26 | 13 | 17.000 | 6.07 | 180.07% |
| 2023-10-08 | 5 | 25 | 14 | 16.800 | 5.88 | 185.71% |
| 2023-10-08 | 4 | 25 | 15 | 18.333 | 5.88 | 211.79% |
| 2023-10-08 | 4 | 25 | 14 | 16.800 | 5.88 | 185.71% |
| 2023-11-28 | 4 | 10 | 7 | 8.333 | 2.70 | 208.63% |
ALDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 15 months, ALDX's average broker recommendation rating worsened by 0.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, ALDEYRA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1753.35% of them.
- In terms of how ALDEYRA THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 323.24% of that group.
- To contextualize these metrics, consider that out of all US stocks, ALDEYRA THERAPEUTICS INC's average analyst price target is greater than 379.18% of them.
- In terms of how ALDEYRA THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1200.36% of that group.
In the Pharmaceutical Products industry, IMUX, KURA, and GALT are the three stocks most similar to ALDEYRA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ALDX using the data that counts. Try POWR Ratings for free.